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CHAPTER ONE
INTRODUCTION
Escherichia coli were discovered in 1885 by a pediatrician, Theodor Escherich.
His bacteriologic studies of infant intestinal flora allowed him to characterize E. coli and
their relation to the physiology of digestion [34]. The harmless strains of Escherichia coli
have a habitat in the bowel of humans and animals. Their primary function in the gut is to
provide the host with vitamin K and prevent the colonization of pathogenic bacteria.
Pathogenic E. coli contain strains that produce toxins resulting in food poisoning. They
can be found in the soil and contaminated water, and are generally ingested with unclean
food or impure drink causing a gastro-intestinal infection. The strains of E. coli
associated with infectious diseases include Enterotoxigenic E. coli (ETEC),
Enteroinvasive E. coli (EIEC), Enterohemorrhagic E. coli (EHEC), Enteropathogenic E.
coli (EPEC) and Uropathogenic E. coli (UPEC) groups. For example, Enteroinvasive E.
coli (EIEC) is found in water polluted with human feces. The transmission usually
occurs through hand-to-hand or hand-to-mouth in unhygienic settings and/or through
ingestion of contaminated food. Usually, the symptoms of bacterial infection are
associated with mucosal abdominal pain, diarrhea, vomiting, and fever. The immunity
against pathogenic E. coli depends on the composition of the bacterial cell surface made
of lipopolysaccharides [32]. As a result, there have been investigations done on the
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pathways and participants involved in the production of lipopolysaccharides in different
strains of E.coli.
Lipopolysaccharides
Lipopolysaccharides (LPS) are glycolipids in Gram-negative bacteria. They are
responsible for many surface characteristics of bacterial cells including non-specific host
defenses and the resistance to detergents, dyes and antibiotics. LPS’s chemistry and their
three dimensional structures prevent many compounds from crossing the outer membrane
and gaining access to the periplasm or peptidoglycan. Lipopolysccharides are
amphiphilic because of a hydrophobic moiety called lipid A and the hydrophilic nature of
saccharides. Specifically, the backbone of lipid A consists of two β-1,6 linked
glucosamine residues which are esterified via the hydroxyl group to fatty acids. The core
of lipopolysccharides contains oligosaccharides which are connected to lipid A via 3detoxy-D-manno-octulosonate (KDO). Lastly, O- antigens or O-polysaccharides
projecting out of the core are carbohydrates made of repeating units of sugars (Figure 1).
The composition of these sugars differs between strains of bacteria. These
oligosaccharides play a structural role in recognition sites in many biological processes
such as antibodies, toxins, and cell recognition [33]. In this thesis, we study the role of
UDP-Glucose Pyrophosphorylase (UDP-Glc PPase) involved in bacterial oligosaccharide
metabolism. UDP-Glc PPase is encoded by a galU gene in both prokaryotes and
eukaryotes. The role of this enzyme is to produce UDP-Glucose (Uridine diphosphate
glucose).

3

Figure 1. Arrangement of gram negative bacteria’s outer membrane. C represents
the Core; O symbolizes oligosaccharides.
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UDP-Glucose in Prokaryotes
Sugar nucleotides such as UDP-Glucose play a role in constructing
oligosaccharides in E.coli. UDP-glucose is a starting point for the production of other
UDP-sugars such as UDP-galactose (Figure 2). One of the enzymes involved in the
synthesis of UDP-glucose is UDP-Glucose Pyrophosphorylase (GalU). UDP-glucose is
also a substrate for the synthesis of UDP-glucuronic acid and required for interconversion of galactose and glucose by the Leloir pathway. There has been a model
presented for UDP-glucose production in E. coli illustrated in Figure 2 [35]. One study
revealed that Mesophilic Aeromonas’ UDP-glucose Pyrophosphorylase (GalU) mutants
reduced the structure of lipopolysaccharides. Specifically, these mutants were unable to
produce O34-antigen and resulted in reduction of pathogenic features [36]. Moreover,
Streptococcus pneumoniae’s GalU had been reported to be essential for capsule
formation and virulence. Acetobacter xylinum’s UDP-glucose takes part in cellulose
synthesis which is used as a substitute for plants’ cellulose in the production of many
commercial products such as paper and cotton textiles [9]. UDP-glucose is also involved
in the production of disaccharides such as trehalose in gram positive bacterium,
Corynebacterium glutamicum, which is used in a wide range of applications in the food
industry [10].

5

Figure 2. Model of UDP-Glucose synthesis in bacteria. Enzymes present are as
follows: 1) glucokinase; 2) glucose-6-phosphate-1-dehydrogenase; 3) 6phosphogluconate dehydrogenase; 4) ribose-phosphate diphosphokinase; 5) orotate
phosphoribosyltransferase and orotidine-5′-phosphatedecarboxylase; 6) uridylate kinase;
7) UDP kinase; 8) phosphoglucomutase; 9) UDPglucose-4-epimerase; 10)
lipopolysaccharide 3-alpha-galactosyltransferase
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UDP-Glucose in Eukaryotes
Uridine diphosphate glucose (UDP-Glucose) is one of the most important sugar
nucleotides in higher plants [2] because it is the major glucosyl donor for carbohydrates,
serving as the direct precursor for synthesis of sucrose. Sucrose is a major product of
photosynthesis in green leaves, accounting for much of CO2 fixed during day time. UDPGlucose’s function in carbohydrate metabolism has not been explained thoroughly.
However, it has been reported that UDP-Glucose may play a critical role in plant growth
and development, at least in some species and/or during some specific developmental
stages. For example, over-expressed bacterial UDP-Glc PPase in transgenic tobacco
revealed an increase in growth and subsequently, increased biomass [6]. Furthermore,
UDP-Glucose is a direct precursor for cellulose and callose synthesis occurring at the
plasmalemma [3].
In addition, UDP-Glucose is involved in the synthesis of carbohydrate moiety of
glycolipids, glycoproteins and proteoglycans, among other functions [4],[5].
In mammals, UDP-Glucose is necessary in the formation of glycogen by providing
glucose to the progressive lengthening of the (α1→4) glycosidic chain. Glycogen is
primarily deposited in the liver and skeletal muscle. Glycogen synthesis in the liver
occurs after food intake as a consequence of the increased glucose level and serves as an
energy supply.
Kinetic mechanism of UDP-Glc PPase
UDP-Glucose Pyrophosphorylase (EC 2.7.7.9) (UDP-Glc PPaase) is one of the
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key enzymes of carbohydrate metabolic pathway widely found in prokaryotes and
eukaryotes. The enzyme catalyzes a reversible formation of uridine diphosphate glucose
(UDP-Glc) and inorganic phosphate from Uridine 3-Phosphate (UTP) and glucose 1phosphate (Glc-1-P) (Figure 3). There is a single displacement of pyrophosphate from
UTP by glucose-1-phosphate. The catalytic activity of UDP-Glc PPase appears to be
initiated by binding of UTP or UDP-Glucose prior to the binding of glucose-1-P or PPi.
The enzyme needs magnesium for its maximal activity [1].
Three dimensional structure of E. coli’s UDP-Glc PPase
Structural analysis of UDP-Glc PPase of E. coli revealed that the protein is a
tetramer and it can be seen as a dimer of dimers (Figure 4). Each subunit contains eight
stranded beta sheets. There are two additional layers of beta strands and ten alpha
helices. In each subunit, Pro-24 has a cis conformation. Val-37 and Asn 151 have
dihedral angles outside of Ramachandran plot and the rest of residues appear to be in
allowed regions of the plot. The enzyme’s subunit contains the elongated globular core
because of present α-helices containing Phe 76-Glu 83, Arg 88-Ser 96 and additional two
helices at C-terminus (Lys-269-Arg 282 and Gly 287-Met 298) which form the “tight
dimer” by subunit-subunit interface [24],[25]. Interestingly, it has been noticed that the
UDP-Glc PPase enzyme is structurally similar to glucose-1-phosphate
thimidylyltransferase [25] and UDP-N-acetylglucosamine pyrophosphorylase [38]. In
addition, there is lower but still significant structural similarity of UDP-Glc PPase to
ADP-Glucose Pyrophosphorylase (ADP-Glc PPase) from bacteria (Agrobacterium
tumefaciens), and CDP-Glucose Pyrophosphorylase from Salmonella typhi [16].
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Figure 3. Kinetic mechanism of UDP-Glc PPase.
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Figure 4. Crystal Structure of UDP-Glc PPase tetramer (Protein Data Bank code is
2E3D). Subunits 1 and 4 and Subunits 2 and 3 form a “tight” dimer meaning they
interact with each other more than Subunits 1 and 2 and Subunits 3 and 4.
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Important residues for the substrate binding
There have been unsuccessful attempts to grow crystals of E. coli UDP-Glc PPase
with the product or its substrate. Since glucose -1-phosphate thymidylytransferase was
crystallized with its substrate and the enzyme is structurally similar to UDP-Glc PPase,
the previous study done by Thoden group [25] was able to build a model of the UDP-Glc
PPase’s active site. The model had shown that Gln-109 serves to anchor the uracil ring
through hydrogen bonding. Furthermore, Gly-17 of UDP-Glc PPase interacts with the 2hydroxyl group of UDP-Glucose. Lys-202 most likely contacts the β-phosphoryl group
of the product while Glu-201 seemed to hydrogen bond with the 2’- and 3’-hydroxyl
groups of the glucosyl moiety. The same study noticed a distorted loop containing Lys84, Arg -85, Val- 86 and Lys -87 close to the active site. It was hypothesized that in the
presence of the substrate or product in UDP-Glc PPase, the enzyme closes down and the
distorted region becomes part of the active site [25]. A three dimensional structure of
Corynebacterium glutamicum’s UDP-Glc PPase with its product, UDP-Glucose,
provided a more defined active site of E. coli’s UDP-Glc PPase. Residues involved in
anchoring the ligand to the active site include Ala-20, Gly-21, Gly-117, Gly-180 and Ala214 and side chains of Glu-36, Gln-112, Asp-143, Glu-201, and Lys-202. The product’s
uracil ring hydrogen bonds to nitrogens of Ala-20 and Gly-117 and the side chain of Gln112 (homologous to E. coli GalU Gln-109 residue (Figure 5)). The ribose’s 2-hydroxyl
group hydrogen bonds to Glu-36, water and Gly-21’s nitrogen. Two magnesium ions are
observed in the crystal structure to be coordinated to the UDP-Glucose of
Corynebacterium glutamicum. The glycosyl group’s 4’hydroxyl interacts with the active
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site via nitrogen of Gly-180 and the carbonyl oxygen of Ala-214. An α- and βphosphoryl oxygen, three waters, and the side chain of Asp-142 ligate the first
magnesium, whereas the second ion is coordinated by the α-phosphoryl oxygen and five
waters [24].
In vivo regulation
There are several levels of regulation that can be envisioned for UDP-Glc PPase.
They involve regulation at the gene expression level (eventually having an effect on
UDP-Glc PPase activity/protein content), but also post-translational regulation (e.g.
protein phosphorylation). Other regulating effects include protein interactions and direct
inhibitory/activating effects of metabolites at the active site of the enzyme. In plants,
abiotic stresses are important factors that affect UDP-Glc PPase’s gene expression. For
example, UDP-Glc PPase from Arabidopsis was highly up-regulated by cold treatment at
both mRNA and protein level [19]. Studies on barley’s UDP-Glc PPase have shown
oligomerization as a regulatory process that affects protein function/activity. For instance,
it has been reported that subtle changes in an immediate environment such as buffer or
protein dilution influence oligomerization of UDP-Glc PPase [2]. In yeast, the
localization and function of UDP-Glc PPase were found to be affected by PAS kinasedependent serine phosphorylation in the N-terminae domain [20]. The in vivo Oglycosylation was reported for mammalian UDP-Glc PPase [21], however, the
significance of this modification is not clear at this moment. Bacterial UDP-Glc PPase
(GalU) interacts with a GalF protein, which modulates its activity in vivo, especially
during stress conditions [22].

12
Evolution of UDP-Glc PPase
All plant UDP-Glc PPases form a single monophyletic group, suggesting a single
ancestral gene. Plant UDP-Glc PPases also have relatively high identity (39%-51%) with
UDP-Glc PPases from the slime mold [12, 5], animals [13] and yeast [14]. However,
eukaryotic UDP-Glc PPases are significantly divergent from those of bacterial origin,
with very little or no identity at the amino acid sequence level [15], [2]. This may indicate
that the genes of eukaryotic UDP-Glc PPase branched off at the very early stage of
evolution, or that they have evolved independently. On the other hand, one study
postulated that the Sucrose Synthase (SuSy) family in plants is homologous with bacterial
UDP-Glc PPase. [2].
Tissue and subcellular localization
UDP-Glc PPase is required for all tissues of all living organisms and it is
considered to be mainly localized in the cytosol. However, in some plants such as in rice
cells had revealed the presence of UDP-Glc PPase in Golgi to some extent. For example,
the fractionation of rice and tobacco cells yielded some UDP-Glc PPase activity in the
microsomes (Golgi bodies) [4]. In barley, relatively high UDP-Glc PPase activities were
found in a membrane fraction [23].
GalF protein
GalF is the protein product of the galF gene that encodes UDP-Glc
Pyrophosphorylase. There is no report published about the crystal structure of the GalF
protein. However, it has been reported that the GalF protein possibly interacts with GalU
to control the production of UDP- Glucose. The galF gene’s product could belong to
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family of bacterial UDP-Glc PPases because the gene is highly conserved among
microorganisms including Haemophilus influenzae [27] and Actobacter xylinum [28].
Protein-protein interactions in vivo between GalU and GalF proteins using the
yeast two hybrid method revealed that the GalF protein possibly interacts physically with
GalU and regulates the biochemical and physical properties of UDP-Glc PPase.
Specifically, the GalF protein causes reduction in the rate of phosphorylysis and provides
a higher thermal resistance for UDP-Glc PPase by increasing in UDP-Glucose production
[22]. It has been proposed that the GalF protein of E. coli is a non-catalytic subunit of
UDP-Glucose Pyrophosphorylase which only physically contacts GalU to regulate the
production of UDP-Glucose. However, a different study reported that the galF gene
(previously called galE) in Salmonella tryphimurium might contain some activity. But,
the galF allele cannot produce large amount of UDP-Glucose as the galU gene. As a
result of that, various mechanisms of interaction between these two proteins were
hypothesized. One hypothesis assumed that the galF gene codes for the product, UDPGlucose, which modifies the polypeptide determined by the galU gene by combining
with it. As a result, the GalF protein cannot produce an active enzyme by itself [26].

CHAPTER TWO
GOAL OF THIS PROJECT
Overall goal of the project
Based on the UDP-Glucose Pyrophosphorylase (GalU) model with
Corynebacterium glutamicum’s UDP-Glucose and magnesium ion, we hypothesized that
Glutamic acid- 201, Glutamine-109, Lysine- 202, Arginine-21, Lysine-31, and Aspartic
acid 265 are residues that play a critical role in the UDP-Glc PPase (GalU) either in
catalysis or binding of substrates.
The second part of this project focused on finding whether the GalF enzyme is
catalytic or not. Also, the alignment of eukaryotic galU and galF amino acid sequences
showed that Threonine-20 and Arginine-21 side chains are missing in GalF. Therefore,
we hypothesized that by mutating these two residues in the galF gene, GalF activity will
be resurrected (if wild type is inactive) or mutations will increase the enzyme’s activity
(if wild type is active).
Part I: Biochemical exploration of UDP-Glc Pyrophosphorylase (GalU) in E.coli
The first part of this project investigates specific amino acids of UDP-Glc PPase
(GalU) that play an important role in the catalytic function. GalU’s monomer contains
302 amino acids and has a molecular weight of 32 kDa. In this study, we tested two
different expression systems, pET28c and pMCSG9, and purified GalU enzymes. We
wanted to see which enzyme would yield a higher degree of purity. Furthermore, to see
14
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whether either purified wild type was significantly affected, we compared their activities
as well as apparent binding affinities to magnesium ions. GalU had been mutated
previously to study potential residues that might be necessary for catalysis. The
mutations already studied were GalUA16V, GalUL248P and GalU P14S which had shown lack
of synthesis of E. coli’s capsular polysaccharide. Therefore, these three residues were
essential for the enzyme’s activity [29].
The E. coli UDP-Glc PPase’s crystal structure was reported without the substrate
[25]. Only recently the structure of Corynebacterium glutamicum was resolved with
UDP-Glucose and two magnesium ions in the active site [24]. Therefore, we performed
a sequence alignment of C. glutamicum UDP-Glc PPase and E. coli UDP-Glc PPase
(Figure 5) to see which amino acids are conserved and potentially catalytic for the E.coli
GalU enzyme. In addition, we built the model of UDP-Glc PPase with the substrate and
one magnesium ion of C. glutamicum UDP-Glc PPase (Figure 6). The model includes
one magnesium ion which is found in the same position among other eukaryotic UDPGlc PPases. To see whether the mutagenesis will change the activity and/or substrate
binding of E. coli’s UDP-Glc PPase, Glutamic acid- 201, Glutamine-109, Lysine- 202,
Arginine-21, Lysine-31and Aspartic acid 265, were chosen to study in this project.
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....|....| ....|....| ....|....| ....|....| ....|....|
10
20
30
40
50
E.coli
----MAAINT KVKKAVIPVA GLGTRMLPAT KAIPKEMLPL VDKPLIQYVV
C.glutamicum MSLPIDEHVN AVKTVVVPAA GLGTRFLPAT KTVPKELLPV VDTPGIELIA

....|....| ....|....| ....|....| ....|....| ....|....|
60
70
80
90
100
E.coli
NECIAAGITE IVLVTHSSKN SIENHFDTSF ELEAMLEKRV KRQLLDEVQS
C.glutamicum AEAAELGATR LAIITAPNKA GVLAHFERSS ELEETLMERG KTDQVEIIR-

....|....| ....|....| ....|....| ....|....| ....|....|
110
120
130
140
150
E.coli
ICPPHVTIMQ VRQGLAKGLG HAVLCAHPVV GDEP--VAVI LPDVILDEYE
C.glutamicum RAADLIKAVP VTQDKPLGLG HAVGLAESVL DDDEDVVAVM LPDDLVLPTG

....|....| ....|....| ....|....| ....|....| ....|....|
160
170
180
190
200
E.coli
SDLSQDNLAE MIRRFDETGH SQIMVEPVAD VTAYGVVDCK GVELAPGESV
C.glutamicum ---VMERMAQ VRAEFGGSVL CAVEVS-EAD VSKYGIFEIE -ADTKDSDVK

....|....| ....|....| ....|....| ....|....| ....|....|
210
220
230
240
250
E.coli
PMVGVVEKPK ADVAPSNLAI VGRYVLSADI WPLLAKTPPG AGDEIQLTDA
C.glutamicum KVKGMVEKPA IEDAPSRLAA TGRYLLDRKI FDALRRITPG AGGELQLTDA

....|....| ....|....| ....|....| ....|....| ....|....|
260
270
280
290
300
E.coli
IDMLIEK-ET VEAYHMKGKS HDCGNKLGYM QAFVEYGIRH NTLGTEFKAW
C.glutamicum IDLLIDEGHP VHIVIHQGKR HDLGNPGGYI PACVDFGLSH PVYGAQLKDA

....|....| ....|....| ....|....
310
320
E.coli
LEEEMGIKK- ---------- --------C.glutamicum IKQILAEHEA AERIADDSQV KLEHHHHHH

Figure 5. Sequence alignment of UDP-Glc PPase (GalU) from E. coli with UDP-Glc
PPase (GalU) from C. glutamicum. The highlighted residues were studied in this thesis.
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Figure 6 . Model of UDP-Glc PPase (GalU) with UDP-Glc and magnesium ion from
C. glutamicum UDP-Glc PPase.

18
Part II: Investigation of putative UDP-Glucose Pyrophosphorylase (GalF) in E.coli
Genes of galU and galF are similar in terms of molecular weight (approximately
32 kD) and amino sequence lengths (galU 302 amino acids and galF 294 amino acids).
Furthermore, the comparison of their amino acids sequences showed that they are 56.6%
identical (Figure 7). In the previous study done on E.coli GalF, it has been proposed that
GalU encodes a catalytically active subunit while the GalF enzyme could serve a
regulatory role [22]. However, the study done on S. tryphimurium GalF revealed that it
may produce a small amount of the product, UDP-Glucose. Thus, in this project we
attempted to purify E.coli GalF to determine GalF’s activity. If GalF is not active or has
a very low activity compared to GalU then there is a possibility that GalF’s and GalU’s
common ancestor was an active subunit and GalF evolved to serve a regulatory role. We
tested two different expression systems, pET24a and pMCSG9, and purified GalF
proteins to compare their activities. In addition, we compared their apparent binding
affinities to magnesium ions.
In this thesis, we also mutated GalF based on the conserved regions of GalU
proteins from bacteria and the homology model of GalF (using GalU crystal structure as a
template). We hypothesized that Threonine-20 and Arginine-21 side chains of GalU are
possible critical residues that the GalF protein lost in evolution which contributed to it
becoming non-catalytic or less-catalytic.
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Figure 7. Sequence alignment of E.coli’s UDP-Glc PPase from galU and galF genes

CHAPTER THREE
RESULTS AND DISCUSSION
Part I: Expression, purification and characterization of GalU
E. coli UDP-Glc PPase (GalU) was purified as indicated in materials and
methods. Based on the amino acid sequence of GalU, its molecular weight is around 32
kDa. However, purified GalU on an SDS-PAGE showed it to be around 39 kDa (Figure
8 and 9). A similar weight was observed in the previous study [15].
GalU’s higher molecular weight value could be due to the fact that it did not bind to SDS
(sodium dodecyl sulfate) efficiently; therefore the electrophoretic mobility was slower,
yielding at higher apparent molecular weight than expected. Hossian group [15] predicted
that the inefficient binding of GalU to SDS could be due to a large number of acidic
residues present in the protein. However, the GalF protein purified in this study has a
similar number of acidic residues (Asp and Glu) as the GalU protein and appeared at the
proper molecular weight on the SDS-PAGE (Figure 17). Therefore, there must be
another factor contributing to GalU’s higher molecular weight on the SDS-PAGE.
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Figure 8. SDS-PAGE of GalU expressed using pET28c vector and purified using 10
ml DEAE Sepharose column. Lanes A3-A11 show the fractions collected from DEAE
Sepharose column. Fractions A6 and A7 showed the greatest enzyme activity and they
were precipitated with ammonium sulfate at 70 % saturation.
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A

B

Figure 9. SDS-PAGE of GalU expressed using pMCSG9 vector and purified using
immobilized metal ion affinity chromatography (IMAC). A) Lane 1: prestained
molecular mass marker; lane 2: crude extract; lane 3 indicates the flow through; lane 4
shows the GalU enzyme (39 kDa) cleaved from the His6-MBP tag (46 kDa). B) Lane 1:
purified GalU; lane 2: ColorPlus prestained protein marker. The SDS-PAGE was
prepared as described in materials and methods.
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Kinetic analysis
The SDS-PAGE containing all enzyme fractions of GalU (pET28c) from the
column showed the intense protein expression in A6-A9 fractions (Figure 8). However,
the highest activity was observed in A6 and A7 fractions. For this reason, these two were
combined and used for further kinetic analysis. The comparison of wild type activities
between the combined A6-A7 fractions and GalU (pMCSG9) revealed a higher Vmax
value or specific activity for GalU (pET28c) (Figure 10). The higher activity of fractions
may be due to differences in stability of different expression systems or differences in
oligomeric states of the enzyme. The binding affinity comparison of the enzyme for
substrates (UDP-Glc or PPi) between GalU (pET28c) and GalU (pMCSG9) did not show
any significant differences (Figure 10).
Since the comparison of two SDS-PAGEs (Figure 8 and 9) showed that GalU
(pMCSG9) yielded purer GalU enzyme (Figure 9) and ensured that no endogenous
enzyme was contaminating the sample, further experiments were performed using the
pMCSG9 expression vector.
Magnesium curve
C. glutamicum UDP-Glc PPase (GalU)’s crystal structure had two magnesium
ions present, but we included only one of them in our model [24]. The magnesium ion
that we incorporated in our model is in the same position as in other eukaryotic UDP-Glc
PPase’s crystal structures. Our model of GalU with the substrate and magnesium ion
from C. glutamicum UDP-Glc PPase (GalU) (Figure 6) showed magnesium ion to be
around 2 Angstroms away from either Pi of UDP-Glc. Our studies indicated that
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magnesium ions were necessary for UDP-Glc PPase’s maximum activity. GalU
enzymes (pET28c and pMCSG9) showed no activity in absence of magnesium ions.
The highest activity for both GalU enzymes was observed upon minimum addition of 2
mM of magnesium ions. Higher concentrations of magnesium did not increase the
activity of either UDP-Glc PPases. Furthermore, the eznymes’ apparent binding
affinities for magnesium ions were not significantly different from each other (Figure
11).
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GalU
GalU

Vector
pET28c
pMCSG9

Specific Activity
(U/mg)

Km (UDP-Glc), mM
118 0.23 ± 0.02
47 0.19 ± 0.01

Km (PPi), mM
0.1 ± 0.01
0.10 ± 0.01

Figure 10. Specific activity and Km comparisons of GalU enzymes. The specific
activity was measured as described in materials and methods.

GalU
GalU
GalF

Vector
pET28c
pMCSG9
pMCSG9

S 0.5 (Mg2+), mM
0.56 ± 0.03
0.65 ± 0.02
1.7 ± 0.3

Figure 11. S0.5 (Mg2+) comparison of GalU and GalF enzymes. The graphs with
different concentrations of magnesium and the corresponding binding affinities of UDPGlc PPases are shown in the appendix section.
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Kinetic analysis of GalU mutants
Based on the previously reported list of hypothetical residues involved in the
activity of UDP-Glc PPase [24], the structural similarity of UDP-Glc PPase to ADP-Glc
PPase and CDP- Glc PPase [16], and our model (Figure 12), six potential catalytic
residues were studied. Glutamic acid- 201, Glutamine-109, Lysine- 202, Arginine-21,
Lysine-31, Aspartic acid-265 were all converted to Alanine.
Lysine-202 was chosen because a homologous Lysine-195 was found to be
important for the substrate binding in ADP-Glc PPase. Specifically, Lys-195 interacts
with β-phosphate of the product, ADP-Glucose, and makes a salt bridge with phosphate
of the substrate, glucose-1-phosphate. The study done on Lys-195 in ADP-Glc PPase
revealed that this residue affects the binding affinity for glucose-1-phosphate [41].
Another study tested ADP-GlcPPase’s Glutamic acid-194 residue which corresponds to
Glutamic acid-201 in E. coli UDP-Glc PPase. The mutation, E194A, revealed that this
residue is involved in the glucose-1-phosphate binding site. In addition, this mutation
had shown a 24-fold decrease in Vmax [16]. E. coli ‘s UDP-Glc PPase mutant D265A was
chosen based on the comparison of ADP-Glc PPase and CDP-Glc PPase active sites. It
had been shown that CDP-Glc PPase’s active site includes the residue D236 whereas
ADP-Glc PPase requires D276 for activity. D276A in ADP-Glc PPase revealed a
decrease of 1000-fold in Vmax compared to wild type, and a 3.4 fold increase S0.5 value for
the substrate, ATP [16]. Based on the hypothetical active site of UDP-Glc PPase and the
comparison to ADP-Glc PPase and CDP-Glc PPase active sites, we hypothesized that the
D265 residue might be critical in activity of UDP-Glc PPase.
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GalU’s Arginine-21 is one of the residues conserved among other UDP-Glc
PPases. Our GalU enzyme model with UDP-Glc and magnesium ion from C. glutamicum
UDP-Glc PPase showed the possibility of the Arginine-21 residue’s involvment in
catalysis because it is pointing towards PPi part of UDP-Glucose (Figure 12). In
addition, the same model showed Lysine-31 to be potentially involved in activity or
substrate binding (Figure 12). Based on the protein/model product in one of the studies,
it has been hypothesized that Glutamine-109 might be a residue necessary for the
substrate binding [25]. Our model showed Glutamine-109 interacting with the Uracil
part of UDP-Glucose, therefore this residue might be involved in UDP-Glucose binding
(Figure 12).
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Figure 12. Models of GalU with UDP-Glc and magnesium ion from C. glutamicum
UDP-Glc PPase (GalU) illustrating six residues mutated in this study.

29
The comparison of specific activities of UDP-Glc PPase constructs revealed that
GalU- R21A is a critical catalytic residue. There was a four order of magnitude decrease
in activity observed by GalU-R21A compared to wild type (Figure 13). Specifically,
GalU-R21A showed 0.003 U/mg activity compared to wild type 47 U/mg. The variation
of PPi (Figure 15) and UDP-Glucose concentrations (Figure 14) did not reveal significant
affects on the binding affinity of GalU-R21A for substrates.
The GalU-D265A and GalU-K31A constructs showed to play an important role in
altering catalysis, yet both residues are not as critical for the maximal activity of UDPGlc PPase as Arginine-21 (Figure 13). Specifically, GalU-D265A and GalU-K31A
showed a decrease in specific activity by two and half orders of magnitude and two
orders of magnitude respectively. Further results showed that the GalU-K31A enzyme
had no significant affect on the PPi or UDP-Glucose binding affinity (Figure 14 & 15).
The binding affinities (Km) for UDP-Glucose in GalU-K31A and wild type were almost
the same revealing 0.18 ± 0.01 mM and 0.19 ± 0.01 mM respectively. Also, Aspartic
Acid-265 did not have an affect on the binding affinity for UDP-Glucose (Figure 14).
However, the same residue was affecting the binding affinity for PPi (Figure 15) showing
1.8 ± 0.3 mM compared to GalU’s Km of 0.10 ± 0.01 mM. This result suggests some
indirect participation of Aspartic Acid-265 in the substrate binding.
The GalU-E201A, GalU-K202A, GalU-Q109A constructs showed the greatest
change in affinity for UDP-Glucose binding compared to wild type and other mutants
(Figure 14). GalU-E201A had a Km of 1.0 ± 0.2 mM, GalU-K202A had 1.1 ± 0.3 mM
binding affinity, and GalU-Q109A had 0.83 ± 0.06 mM compared to GalU that had Km of
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0.19 ± 0.01 mM. Specific activities for all three mutants were not significantly changed.
Out of all three mutants, GalU-E201A had the highest effect on enzyme’s activity with a
decrease of about two orders of magnitude (Figure 13). GalU ’s E201A (Km of 0.94 ±
0.16) and GalU-D265A (Km of 1.8 ± 0.3) mutants showed to affect the binding of
pyrophosphate compared to wild type (Km of 0.10 ± 0.01), which indicates that these two
residues play a role in the binding of substrates.
Conclusions
The catalytic characterization of GalU revealed a decrease in UDP-Glucose
Pyrophosphorylase activity of all mutants. Out of all mutated residues, Arginine-21 was
the most critical catalytic amino acid since the mutation showed the highest drop in
activity compared to wild type. Glutamine-109 was important for the binding with Uracil,
demonstrating its specificity for this type of enzyme. Lysine-202 and Glutamic Acid-201
had recognition for the sugar, UDP-glucose, but they were not important for the
enzyme’s specificity. Aspartic Acid-201 indirectly participated in the pyrophosphate
binding.
Magnesium ions were critical for UDP-Glc PPase’s activity. Furthermore,
approximately 2 mM was the minimal concentration of magnesium necessary for the
enzyme’s maximal activity.
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Log Vmax (U/mg)
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1

0.1

0.01

1E-3

galU

D265A K31A

R21A E201A K202A Q109A

UDP-Glc PPase constructs

Figure 13. Specific activity (Vmax) comparison of UDP-Glc PPase (GalU) constructs.
Vmax for GalU was 47 ± 3.0 U/mg; GalU D265A 0.29 ± 0.02 U/mg; GalUK31A 0.10 ± 0.02
U/mg; GalUR21A 0.003 ± 0.0009; GalUE201A 0.43 ± 0.07 U/mg; GalUK202A 6.9 ± 0.2
U/mg; GalUQ109A 19 ± 2 U/mg. The specific activities were measured as described in
materials and methods.
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1.6

Km of UDP-Glucose (mM)

1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
galU

D265A

K31A

R21A

E201A K202A Q109A

UDP-G lc PPase constructs

Figure 14. Km comparison of GalU constructs while varying UDP-Glucose
concentrations. The exact Km (mM) for each construct were as follows: GalU 0.19 ±
0.01; GalU-D265A 0.09 ± 0.05; GalU-K31A 0.18 ± 0.02; GalU-R21A 0.11 ± 0.04;
GalU-E201A 1.0 ± 0.2; GalU-K202A 1.1 ± 0.3; GalU-Q109A 0.83 ± 0.06. The graphs
with different concentrations of UDP-Glucose and the corresponding specific activities of
UDP-Glc PPase constructs are shown in the appendix A section.
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Figure 15. Km comparison of GalU constructs while varying PPi concentrations.
Km (mM) for GalU was 0.10 ± 0.01; 2: GalU D265A 1.8 ± 0.3; GalUK31A 0.21 ± 0.01;
GalUR21A 0.09 ± 0.01; GalUE201A 0.94 ± 0.16; GalUK202A 0.11 ± 0.02; GalUQ109A 0.08 ±
0.01. The graphs with different concentrations of PPi and the corresponding specific
activities of the UDP-Glc PPase constructs are shown in the appendix A section.
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Part II: Expression, purification and characterization of GalF
The expression of GalF proteins (expressed in both pET24a and pMCSG9) from
the galF gene appeared to be around 30 kDa just as predicted by amino acid sequence
(Figure16 &17).
Kinetic analysis
The measurement of specific activities of GalF proteins (pET24a and pMCSG9)
indicated that GalF is active. Specifically, GalF (pET24a) revealed 0.02 U/mg (using 0.1
mM PPi) activity and GalF (pMCSG9) had 0.12 U/mg (0.1 mM PPi) and 0.24 ± 0.06
U/mg (0.5 mM PPi). The difference in activity may be due to differences in stability
using different expression systems. Despite the fact that there was a significant difference
in activity between GalF proteins, these results suggest that the ancestry of GalF was a
catalytic subunit that became reduced in activity as it evolved.
Further experiments were performed using pMCSG9 vector.
Magnesium curve
Our studies indicated that magnesium ions were necessary for the maximum
activity of GalF. The comparison of apparent binding affinities between GalF and GalU
enzyme showed that the GalF enzyme has lower binding affinity for magnesium ions
(Figure 11). As a result, GalF needs higher concentration of magnesium for its maximal
activity. Approximately 5 mM of magnesium was necessary to detect the highest activity
of GalF.
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Figure 16. SDS-PAGE of GalF expressed using pET24a vector and purified using
10 ml DEAE Sepharose column. Lane 1 shows the prestained protein marker; Lane 2
&3 shows GalF enzyme around 30 kDa.
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Figure 17. SDS-PAGE of GalF expressed using pMCSG9 vector and purified using
immobilized metal ion affinity chromatography (IMAC). Lane 1 represents the
prestained protein marker; Lane 2 is a crude extract; Lane 3: the flow through; Lane 4
indicates GalF enzyme cleaved from His6-MBP tag; Lane 5 shows pure UDP- Glc PPase
(GalF).
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Kinetic comparisons of GalU, GalF and GalF mutant
Based on analysis of the active site of GalU reported in the previous study [24]
and conserved residues among bacterial GalU proteins that are missing in GalF
(Figure 18), the hypothetical catalytic residues were chosen to be studied in this project.
Since the three dimensional structure of the GalF protein has not been reported yet, we
modeled this enzyme based on the GalU’s crystal structure (Figure 19). Also, our model
includes the substrate and magnesium ion using C. glutamicum UDP-Glc PPase (GalU)
as a template. We hypothesized that mutations of Histidine-20 into Threonine and
Methionine-21 into Arginine, could potentially resurrect the activity of GalF (if wild type
is inactive) or increase the activity of GalF (if wild type is active).
The specific activities and binding affinities for substrates (PPi and UDP-Glucose)
between GalF and GalF- M15T, H16R were not changed significantly (Figure 20, 21 &
22). These results revealed that the two mutations on GalF had no effect on the enzyme’s
activity and it did not affect the binding affinity for either substrate (UDP-Glc or PPi).
Threonine and Arginine may not be the only residues that cause low activity of GalF.
The specific activities of GalU and GalF (or GalF- M15T, H16R) showed a 100fold decrease for GalF. Specifically, GalF’s Vmax was 0.24 ± 0.06 U/mg while GalU had
the specific activity of 47 ± 3.0 U/mg (Figure 20). Further kinetic analysis revealed that
the GalF protein affected binding affinities for UDP-Glucose and PPi compared to the
GalU enzyme (Figure 21, 22). For example, the binding affinity of PPi for GalU was
0.10 ± 0.07 mM compared to GalF that revealed 0.04 ± 0.07 mM (Figure 22).
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E. coli GalU
C.glutamicum GalU
E. coli GalF

....|....|
10
----MAAINT
MSLPIDEHVN
----MTNL--

....|....|
20
KVKKAVIPVA
AVKTVVVPAA
---KAVIPVA

....|....|
30
GLGTRMLPAT
GLGTRFLPAT
GLGMHMLPAT

....|....|
40
KAIPKEMLPL
KTVPKELLPV
KAIPKEMLPI

Figure 18. UDP-Glc PPase sequence comparison. The highlighted are the conserved
residues of GalU proteins that are missing in GalF enzyme.
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Figure 19. Homology model of GalF using E. coli GalU as a template and UDP-Glc,
magnesium ion from C. glutamicum GalU. The model shows two residues that were
mutated in this study. Specifically, Methionine was mutated to Threonine whereas
Histidine was replaced by Arginine.
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Conclusions
It has been reported that the galF gene does not encode an active UDP-Glc PPase,
however, our study revealed that GalF is an active enzyme. Yet, the protein’s specific
activity was 100-fold lower compared to GalU. This result suggests that the ancestry of
GalF is a catalytic subunit and that it became reduced in activity as it evolved.
The saturation curve revealed that GalF needs magnesium ions in order to be
active. The comparison of binding affinities between GalF and GalU showed that GalF
requires a higher concentration of magnesium in order for its maximal activity to be
detected. The two mutations performed on the galF gene did not affect GalF’s activity
and they did not have an effect on the binding affinity of UDP-Glc or PPi.
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Figure 20. Vmax comparison of UDP-Glc PPases. Vmax for GalU was 47 ± 3.0 U/mg;
GalF 0.24 ± 0.06 U/mg; GalF-M15T, H16R 0.21 ± 0.09 U/mg. The specific activities
were measured as described in materials and methods.
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Figure 21. Km comparison of UDP-Glc PPases using different UDP-Glucose
concentrations. The specific Km of GalU was 0.19 ± 0.01, GalF was 0.78 ± 0.11 and
GalFM15TH16R was 0.86 ± 0.08. The graphs with different concentrations of UDP-Glucose
and the corresponding specific activities of UDP-Glc PPases are shown in the appendix
A.
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Figure 22. Km comparison of UDP-Glc PPases using different PPi concentrations.
GalU’s Km was 0.10 ± 0.01; Km of GalF was 0.04 ± 0.01; GalFM15H16R 0.06 ± 0.01. The
graphs with different concentrations of PPi and the corresponding specific activities of
UDP-Glc PPases are shown in the appendix A.

CHAPTER FOUR
MATERIALS AND METHODS
Structure prediction and homology modeling
The homology modeling was performed with the program Modeller8v2. GalU
and GalF models included the product UDP-Glucose and magnesium ion form C.
glutamicum UDP-Glc PPase (PDB ID: 2PA4). The crystal structure of GalU (PDB ID:
2E3D) was used as a template for the GalF model. The alignment was performed using
Bioedit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The secondary structure
prediction was performed with the PSI-PRED method [45] available on the PSI-PRED
server (bioinfo.cs.ucl.ac.uk/psipred/) [46]. The pdb files were viewed on
DeepView/Swiss-PDBViewer 3.7. Verification of models was performed using the
program called Verify3D (nihserver.mbi.ucla.edu/Verify_3D/) [43]. VMD,
Swiss-PdbViewer and POV-ray programs (http://www.povray.org/) were used to picture
the models. The sequence alignments and Verify3D graphs can be found in the appendix
B.
Cloning of galU and galF genes from E. coli genome
The cloning process was performed by Misty Khun. XL1-Blue cells were grown
in 5 ml Luria-Bertani (LB) Media overnight at 37 ˚C. After 12-15 hours, the cells were
purified using the Promega’s Wizard Genomic DNA Purification Kit to obtain E. coli’s
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genomic DNA. Then, the DNA was digested with Hind III and Xba I restriction sites in
order to obtain the pieces of the E. coli’s genome. These restrictions sites were chosen
because they did not cut through galU and galF genes. Next, TAG PCR was performed
containing the mixture of 1 µl of digested genomic DNA, 25 µl GO-TAG Green Master
Mix 2x, 2.5 µl of each primer and 19 µl of nanopure-di-water. The mixture was placed in
the thermocylcer (initial denaturation of 30 seconds at 98˚C, 30 cycles of 98 ˚C for 30
seconds, 50 ˚C for 20 seconds, 72 ˚C for 1 minute and 5 minute extension at 72 ˚C) and
then run on the agarose gel electrophoresis 80 V for 60 minutes. The correct size band
for the galU gene was 906 bp while for the galF gene was 894 bp. The galU and galF
bands were extracted, purified, ligated into a Strataclone vector. The transformation into
E .coli XL1-Blue cells (Stratagene) and further steps were exactly followed as described
under Site-directed mutagenesis section.
Primers for cloning of galU gene from E.coli genome
Forward 5’-ATG GCT GCC ATT AAT ACG AAA GTC AAA AAA GCC GTT
ATC CCC GTT GCG GG-3’ reverse 5’- TTA CTT CTT AAT GCC CAT CTC TTC
TTC AAG CCA GGC TTT AAA TTC CGT GC-3’
Primers for cloning of galF gene from E.coli genome
Forward: 5-ATG ACG AAT TTA AAA GCA GTT ATT CCT GTA GCG GGT
CTC GGG ATG CAT AT-3’ and reverse: 5’-TTA TTC GCT TAA CAG CTT CTC AAT
ACC TTT ACG GAA CTT CGC CCC TTC TT-3’
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Site-directed mutagenesis
The sequences of galU and galF E. coli were obtained from the GenBank
(http://www.ncbi.nlm.nih.gov/) for visualization. The primers for galU and galF genes
containing mutations were designed using the program called BioEdit
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Site-directed mutagenesis was
performed using Sambrook’s laboratory manual with some modifications [37]. Phusion
PCR was performed to obtain the PCR product (mutated gene). The PCR mixture
contained 32.5 µl of water, 10 µl of 5x Phusion HF buffer, 1 µl of 10 mM dNTPs, 2.5 µl
of primers, 0.5 µl of DNA template (3mg/µl) and 0.5 µl of Phusion DNA polymerase.
The PCR mixtures were run in the thermocyler (initial denaturation of 30 seconds at
98˚C, 30 cycles of 98 ˚C for 30 seconds, 50 ˚C for 20 seconds, 72 ˚C for 1 minute and 5
minute extension at 72 ˚C) then the PCR products were run on agarose gel
electrophoresis. The correct bands were extracted, purified and another phusion PCR
was performed using these bands as the template DNAs with the appropriate flanking
primers. Next, the final PCR product was ligated into a Strataclone vector and
transformed into E .coli XL1-Blue cells (Stratagene) using the StaraClone Blunt PCR
Cloning kit. Transformants were plated on carbenicillin plates in the presence of X-gal
and they were left in the incubator at 37 °C overnight for blue-white colony screening
[37]. The presence of white colony represents a successful ligation of a vector into a
desired gene. The mechanism is based on genetic engineering of the lac operon in the E.
coli laboratory with a complemented subunit from the cloning vector. The vector encodes
α subunit of LacZ protein with an internal multiple cloning site and the chromosome of
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E.coli (a host cell) encodes β-galactosidase. The DNA of interest is inserted within the
lacZ gene which disrupts the production of β-galactosidase and appears as a white
colony. White, bacterial colonies were picked, purified and colony PCR was performed
[37]. Agarose gel electrophoresis analysis allowed us to verify whether the vector was
inserted into a gene (Figure 23). The correct band was extracted, purified and confirmed
by DNA sequencing at University of Chicago Cancer Research Center, DNA Sequencing
Facility. The galU and galF genes were sub-cloned into expression vectors pet28c and
pet24a (Novagen) respectively and both of them were sub-cloned into pMCSG9 vector
[39]
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Figure 23. Example of 1.2 % agarose gel electrophoresis showing galF in
Strataclone vector. Lane 1: 1 kb ladder; Lane 2: galF band. The correct size band for
galFshould be around 894 bp which is approximately what is observed on the gel above.
The galF band was extracted and purified as described in materials and methods.
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Primers used for site-directed mutagenesis
galU
Site- directed mutagenesis was performed by PCR overlap extension using the
procedure listed under Site Directed Mutagenesis. galU-R21A forward (5’-TTA GGA
ACC GCG ATG TTG CCG-3’) and reverse (5’-CGG CAA CAT CGC GGT TCC TAA3’), galU-K31A forward (5’-GCC ATC CCG GCG GAG ATG CTG-3’) and reverse (5’
CAG CAT CTC CGC CGG GAT GGC-3’), galU-Q109A forward (5’- CAA GTT CGT
CGC GGT CTG GCG-3’) and reverse ( 5’- CGC CAG ACC CGC ACG AAC TTG-3’),
galU-D265A forward (5’-AAG AGC CAT GCG TGC GGT AAT-3’) and reverse (5’ATT ACC GCA CGC ATG GCT CTT- 3’), galU-E201A forward (5’- GGT GTG GTA
GCG AAA CCG AAA-3’) and reverse (5’ – TTT CGG TTT CGC TAC CAC ACC-3’),
galU-K202A forward (5’-GTG GTA GAA GCG CCG AAA GCG-3’) and reverse (5’CGC TTT CGG CGC TTC TAC CAC-3’).
galF
galF M15T H16R forward direction (5’- GGT CTC GGG ACC CGT ATG TTG
CCT-3’) and reverse (5’-AGG CAA CAT ACG GGT CCC GAG ACC-3’).
Flanking primers for galU and galF genes
Forward 5’-TAA TAC GAC TCA CTA TAG GG- 3’ and reverse 5’-GCT AGT
TAT TGC TCA GCG G-3’
pMCSG9 vector
The pMCSG9 vector [39] was used to purify the proteins of interest. It contains a
his6 tag bound to a maltose binding protein (MBP). The his6 tag allows the protein of
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interest to be purified using the immobilized metal ion affinity chromatography (IMAC)
[44]. The maltose binding protein (MBP) improves solubility and there is also a TEVprotease site in order to cleave the protein of interest from the his6-MBP tag (Figure 24).
The advantage of using this vector for the protein expression and purification is that it
selectively purifies the protein containing his6-MBP tag and therefore eliminates the
possibility to have interference with endogenous activity.
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Figure 24. Simple model of pMCSG9 vector with the galU gene.

52
Subcloning genes into pMCSG9 vectors
Genes of galU and galF were amplified by phusion PCR. The primers used for
GalU wild type and mutants had the same construct. galU forward 5’- TAC TTC CAA
TCC AAT GCC GCA GCA ATG GCT GCC ATT AAT ACG AAA GTC AAA-3’ and
reverse 5’- TTA TCCACT TCC AAT GTT ACT TCT TAA TGC CCA TCT CT-3’.
GalF and galF-M15T H16R forward 5’-TAC TTC CAA TCC AAT GCC GCA GCA
ATG ACG AAT TTA AAA GCA GTT ATT CTT-3’ and reverse 5’- TTA TCC ACT
TCC AAT GTT ATT CGC TTA ACA GCT TCT CA-3’. The purified PCR product
from agarose gel electrophoresis was cloned into pMCSG9 vector [39], [40]. The gene
was cloned into this vector using ligation independent cloning (LIC). The starting
mixture contained 1 µl 5mM dCTP, 2 µl T4 polymerase buffer 10x, 1 µl 3mM DTT, 15
µl of PCR gene product, 0.5 µl of water and the reaction was initiated by 0.5 µl of T4
DNA polymerase. The mixture was placed into a thermocycler at 25 °C for 25 minutes
and at 75 °C for 20 minutes. Next, the mixture was allowed to cool for 1 hour and 2 µl of
pMCSG9 vector was added into a mixture and incubated at room temperature for 10
minutes. 2 µl of the plasmid mix were added into 100 µl of BL21 (DE3) Magic cells and
incubated on ice for 10 minutes. The soc medium was added to the mix and left shaking
for 1 hour at 37°C. Afterwards, the cells were plated on kanamycin/ampicillin LB agar
plates and incubated overnight at 37°C. Next day, some colonies were picked and
checked by using the colony PCR procedure.
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Colony PCR procedure
One colony from the LB agar plate was chosen by touching the colony with a
toothpick and scratched inside the 0.2 ml PCR individual tubes. 20 µl of nuclease free
water, 2.5 µl of the appropriate primers for the gene, and 25 µl of 2x Green Master Mix
were added into a 0.2 ml PCR tube with a colony in it. Next, the PCR tube with its
contents was placed in a thermocycler using a program that starts with denaturation at
95°C for 5 minutes, then 25 cycles of 1 minute at 95 °C, 30 s at 50 °C and 1 minute at 72
°C with the final extension at 72 °C for 5 minutes. Then the mixture was run on 1.2 %
agarose gel electrophoresis. The gel was visualized with GIMP2 program and if the band
of the gene was correct then its DNA was sequenced.
DNA sequence visualization
The Bioedit program was used to see DNA sequence of the gene. The
program was downloaded from http://www.mbio.ncsu.edu/BioEdit/bioedit.html website.
pET vector
The pET vector is used for the expression of recombinant protein in E. coli. The
pET vector contains bacteriophage T7 transcription and translation signals, and the
expression is induced by providing a source of T7 RNA polymerase in the host cell. The
pET vector is good at expressing wild type protein; however it is not the best choice for
the protein containing mutation(s). The mutated protein expressed using pET vector
maybe mixed with endogenous wild type. This contamination may result in inaccurate
mutated enzyme’s activity. Thus, the vector containing tag such as pMCSG9 is a better

option for expressing the mutated protein.
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Subcloning genes into pET vectors
Genes of galU and galF in Strataclone vectors were digested with pET vectors
(Novagen). The digestion tube for galU contained buffer #1(Novagen), NcoI and SacI
restriction enzymes obtained from NEW ENGLAND Biolabs Inc, the pET28c vector
(http://www.genomex.com/vector_maps/pET28_map.pdf ) and galU (Strataclone). The
digestion tube for the galF gene contained buffer #4 (Novagen), NdeI and SacI restriction
enzymes, the pET24a vector (http://www.genomex.com/vector_maps/pet24a-d.pdf ) and
galF (Strataclone). The digestion contained 10:1 ratio of the gene to vector. The
digestion tubes were placed in the water bath at 37 °C overnight. Next, PCR clean-up
was performed using the protocol in Wizard SV Gel and PCR Clean up system
(Promega). Next, the quick ligation was performed by pipeting out 10 µl of the PCR
clean up system product into a new 1.5 ml microcentrifuge tube. 10 µl of 2X quick ligase
buffer (New England Bio Labs Inc) and 1 µl of the quick T4 DNA ligase (New England
Bio Labs Inc) were added into 10 µl PCR product. The mixture was briefly centrifuged
and incubated on ice for 5 minutes. Then, 2 µl of the mixture was used to transform it
into NEB Turbo cells (NEW England Biolabs Inc) and plated on kanamyocin plates.
Lastly, the colony PCR was performed to check whether the vector was inserted into a
gene. The flanking primers were used for the colony PCR for both pETgalU anf pETgalF.
Expression and purification of GalU and GalF from pET vectors
pETgalU and pETgalF were transformed into E. coli BL21 (DE3) cells
(Novagen). The single colony were grown at 37 °C in 1 liter of Luria-Bertani medium
with kanamycin (50 µg/ml) and shaked until an optical density of 0.6-0.7 was reached at
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600 nm. The culture was induced with 1M of IPTG and allowed to grow for an
additional 16 hours at 20°C before harvesting and centrifugating (2.5 rpm for 5 minutes).
Next, the supernatant was discarded and the pallet was sonicated in buffer A (50m M
HEPES, pH 8.0, 5 mM MgCl2, 0.1 mM EDTA, 10% sucrose). The solution was
centrifuged again at 12 rpm for 20 minutes and stored at -80 °C. The purification was
performed at 0 to 4°C. The crude extract was applied onto 10 ml DEAE- Sepharose
column using Akta FPLC UPC-900 (Amersham Biosciences) equilibrated in buffer A
and the fractions were eluted with linear gradient of NaCl. The fractions were collected
and the enzyme was monitored by pyrophosphorolysis activity.
Expression of GalU and GalF from pMCSG9 vectors
Single colony of BL21 (DE3) “Magic” cells containing pMCSG9 vector were
grown overnight at 37 °C in 5 ml LB medium containing sterile 5 µl of 1000x ampicillin
and 5 µl of 1000x kanamyocin. On the next day, the 5 ml starting culture was poured
onto a 1ml LB medium and 1ml of 1000x ampicillin plus 1ml of 1000x kanamyocin were
added. The culture was grown at 25°C shaking at 250 rpm until the OD600 reached 0.60.8. Next, the culture was put on ice and cooled to 16°C. The protein was expressed by
an addition of 0.5 mM of IPTG and left shaking at 16°C. After around 16 hours, the cells
were harvested by centrifugation 2.5 rpm for 5 minutes in SS34 rotor. The cells were resuspended in the appropriate volume (5 ml of buffer per 1 gram of cells) of buffer C
containing 200 mM NaCl, 20 mM Tris pH 8.0, 10% glycerol and sonicated on ice using
the Misonix sonicator 3000 for 4 minutes total (30 seconds on, 45 seconds off). Lastly,
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the cells were centrifuged in the SS34 rotor for 20 minutes with speed of 12 rpm after
which the supernatant (crude extract) was retained and poured onto a Nickel column.
Purification of GalU and GalF from pMCSG9 vectors
The crude extract obtained from last centrifugation was loaded onto a Ni-NTA
Aragose resin (Qiagen). The Ni-NTA column with the crude extract was slowly shaken
up and down for 1 hr so that the maximum amount of protein attaches to the resin. Then
the column was centrifuged at 2000 rpm for 2 min and the flow through was collected
which was then put in -80 °C. Next, three column volumes (15 ml) of buffer C were
added to the Nickel column in order to wash the unbound protein. The column was then
inverted slowly using Barnstead/Thermolyne Labquake Shaker (Rotisserie) for 5 minutes
and the wash was collected after centrifugation (2000 rpm for 2 min). The protein was
eluted after the addition of combined buffer C and 300 mM of Buffer E (1 M imidazole,
200 mM NaCl, 20 mM Tris pH 8, 10% glycerol). Again, the column was shaken for 5
minutes and centrifuged to obtain the protein (once the protein was eluted, the column
needed to be washed with 3 column volumes of mixture of buffer C and 500 mM buffer
E and 2 volume columns washes with buffer C). The collected fraction containing the
protein was treated with 5 mM EDTA and approximately 4 mg of TEV (tobacco Etch
Virus) Protease stirring overnight at 4 °C. Next, the protein was precipitated with
ammonium sulfate of 60 % saturation and centrifuged to remove any imidazole. The
protein was re-suspended in buffer C (200 mM NaCl, 20 mM Tris pH 8.0, 10% glycerol)
and loaded onto a Ni-NTA resin. The column was shaken up and down for 1 hr,
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centrifuged and the elute (protein) was collected. Afterwards, the column was washed
with buffer C and higher concentration of buffer E as described above.
Measuring protein concentration
The concentration of purified protein was measured using a NanoDrop ND-1000
Spectrophotometer with an extinction coefficient of 1 AU/mg-1 ml-1. The procedure was
exactly performed as provided by the manufacturer. The module displays the UV
spectrum and measures the protein’s absorbance at 280 nm to calculate the concentration
in mg/ml automatically.
SDS-PAGE preparation
Electrophoresis was performed using 1.5 mm cassette. The separation gel was
made from 3.125 ml of 40% of acrylamide, 4.7 ml of separating gel buffer (1M Tris-HCl,
pH 8.8), 125 µl of 10% SDS, 125 µl of catalyst ( 0.1 g Ammonium Persulfate in 960 µl
of water), 2 ml of 50% sucrose, 5 µl of TEMED and 2.55 ml of water. Next, n-butanol
was poured onto the top of separating gel to eliminate any bubbles formed. The gel was
left for a while until it hardened. Then the gel was flushed with de-ionized-nanopure
water to remove the excess of n-butanol. The stocking gel was poured onto the separating
gel. The mixture of stocking gel included 0.4 ml of 40% acylamide, 1.56 ml stocking gel
buffer (0.5 M Tris-Hcl pH 6.8), 62.2 µl of 10% SDS, 0.25 ml of catalyst (0.1 g
Ammonium Persulfate in 960 µl of water), 2.5 µl of TEMED and 4 ml of water. The
sample containing 5-10 µl of crude extract or fraction after purification was mixed with
2-Mercaptoethanol, 2x sample buffer (stocking buffer, glycerol, 10% SDS, water, 0.2 %
bromophenol blue and 2-Mercaptoethanol) and run on the thermocycler for 10 minutes.
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Afterwards, the samples were loaded onto the gel and run for 60 minutes, 200 Volts. The
1X Tris-HEPES-SDS (Invitrogen) buffer was used for electrophoresis. The New
England Biolabs prestained protein marker broad range was used to estimate protein’s
molecular weight. The gel was stained with Pierce (Rockford, IL, USA) Gel Code Blue
Stain Reagent.
Enzyme assay: Pyrophosphorolysis direction
The UDP- Glucose Pyrophosphorylase activity was measured in the reverse
direction (Pyrophosphorolysis), from UDP-glucose and PPi to Glucose-1-P and UTP.
The reaction mixture (300 µl) contained 80 mM HEPES at 8.0 pH, 7 mM of MgCl2, 2
mM of DTT, 0.5 mM of UDP- glucose, 0.6 mM of NAD+ , 10 mM of NaF, 0.01 mM of
G1,6BP, 2 U/ml of PGM (Phosphoglucomutase preparation from Rabbit muscle), 2 U/ml
of G6PDH (glucose-6-phosphate dehydrogenase form Leuconostoc mesenter),
0.2 mg/ml of bovine serum albumin, de-ionized-nanopure water and 10 µl of enzyme.
The reaction was initiated by the addition of 0.5 mM of NaPPI and placed into the
spectrophotometer (BioTek EL 808) (Figure 24).
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Figure 25. Spectrophotometric coupled enzyme essay of UDPGlucose in the pyrophosphorolysis directrion. The essay
monitors enzyme activity.
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Calculation of kinetic constants
The kinetic assays were performed at optimal conditions for all reaction mixtures.
The data was plotted for different concentrations of PPi (mM) on x-axis versus the
activity (nmol/min) on y-axis. Then, we used Origin 7.5 program which contains the
modified Hill equation for a non-linear curve fit, V = Vo + (Vmax - Vo) * sn / (kn + sn)
[42]. V is the velocity while Vmax is the maximum velocity at saturation. S symbolizes the
substrate and k is the amount of substrate concentration needed to obtain 50% maximum
velocity. We varied Vmax and k parameters to get the best possible fit. The same process
was used for the data with variation of UDP-Glucose (mM).

APPENDIX A:
KINETIC GRAPHS OF UDP-GLC PPASES
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2+

GalU (pMCSG9): varying [Mg ]
Conditions: 50 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

Activity (nmol/min)

2.0

1.5

1.0

0.5

0.0

0

1

2

3

4

5

6

MgCl2 (Mm)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.98966
START
0
0
END 1.8819 0.02842
k
0.65024
0.02462
n
2.59794
0.23154
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GalU (pMCSG9): varying [UDP-Glc]
Conditions: 25 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

1.2

Activity (nmols/min)

1.0
0.8
0.6
0.4
0.2
0.0
0.0

0.5

1.0

1.5

2.0

UDP-glucose (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2
= 0.99271
START 0
0
END 1.24149
0.02428
k
0.19139
0.01371
n
1
0
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GalU (pMCSG9): varying [PPi]
Conditions: 25 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

1.2

Activity (nmol/min)

1.0
0.8
0.6
0.4
0.2
0.0
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99345
START
0
0
END 1.04998
0.02703
k
0.10099
0.00718
n
1.8
0
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2+

GalU (pET28c): varying [Mg ]
Conditions: 30 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.
3.0

Activity (nmol/min)

2.5

2.0

1.5

1.0

0.5

0.0

0

1

2

3

4

5

6

MgCl 2 (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.97692
START
0
0
END 2.54289
0.05167
k
0.55861
0.03137
n
2.43611
0.30328

66
GalU (pET28c): varying [UDP-Glc]
Conditions: 7.4 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

2.0
1.8

Activity (nmol/min)

1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
0.0

0.2

0.4

0.6

0.8

1.0

UDP-Glc (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99738
START
0
0
END 2.29102
0.05896
k
0.22878
0.01513
n
1
0
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GalU (pET28c): varying [PPi]
Conditions: 7.4 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

1.6

Activity (nmol/min)

1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99548
START
0
0
END 1.57189
0.03174
k
0.10048
0.00619
n
1.4
0
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GalU D265A: varying [UDP-Glc]
Conditions: 9.4 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.
1.6
1.4

Activity (nmols/min)

1.2
1.0
0.8
0.6
0.4
0.2
0.0
0.0

0.5

1.0

1.5

2.0

UDP- glucose (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.90523
START
0
0
END 1.67659
0.1209
k
0.09162
0.04779
n
0.4
0
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GalU D265A: varying [PPi]
Conditions: 47 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

7

Activity (nmol/min)

6
5
4
3
2
1
0
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99755
START
0
0
END 19.42007
2.44702
k
1.82909
0.32501
n
1
0
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GalU K31A: varying [UDP-Glc]
Conditions: 9.4 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.
1.0

Activity nmol/min

0.8

0.6

0.4

0.2

0.0
0.0

0.5

1.0

1.5

2.0

UDP - glucose (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.97347
START
0
0
END 0.8706 0.03074
k
0.17859
0.02361
n
1
0

71
GalU K31A: varying [PPi]
Conditions: 28 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

3.5

Activity (nmol/min)

3.0
2.5
2.0
1.5
1.0
0.5
0.0
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99659
START
0
0
END 3.65974
0.0912
k 0.20532 0.01227
n 1.6 0
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GalU R21A: varying [UDP-Glc]
Conditions: 12 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods

0.035

Activity (nmol/min)

0.030
0.025
0.020
0.015
0.010
0.005
0.000
0.0

0.5

1.0

1.5

2.0

UDP-glucose (mM)

.
Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.82161
START
0
0
END 0.03205
0.00235
k 0.11306
0.03823
n 1.3 0
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GalU R21A: varying [PPi]
Conditions: 24 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.
0.08
0.07

Activity (nmol/min)

0.06
0.05
0.04
0.03
0.02
0.01
0.00
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.97648
START
0
0
END 0.07584
0.00348
k 0.089
0.01469
n 1 0
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GalU K202A: varying [UDP-Glc]
Conditions: 39 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.
0.40
0.35

Activity (nmol/min)

0.30
0.25
0.20
0.15
0.10
0.05
0.00
0.0

0.5

1.0

1.5

2.0

UDP-glucose (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.97609
START
0
0
END 0.52169
0.06211
k
1.12752
0.27321
n
1
0
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GalU K202A: varying [PPi]
Conditions: 39 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.
0.35
0.30

Activity (nmol/min)

0.25
0.20
0.15
0.10
0.05
0.00
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.98586
START
0
0
END 0.33377
0.01384
k
0.11105
0.01561
n
1
0
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GalU Q109A: varying [UDP-Glc]
Conditions: 12 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

0.30

Activity (nmol/min)

0.25
0.20
0.15
0.10
0.05
0.00
0.0

0.5

1.0

1.5

2.0

UDP-glucose (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99734
START
0
0
END 0.42744
0.01363
k
0.82958
0.06004
n
1
0
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GalU Q109A: varying [PPi]
Conditions: 12 ng of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

0.40

Activity (nmol/min)

0.35
0.30
0.25
0.20
0.15
0.10
0.05
0.00
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99208
START
0
0
END 0.41432
0.0101
k
0.08016
0.00722
n
1
0

78
GalU E201A: varying [UDP-Glc]
Conditions: 0.6 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

Activity (nmol/min)

0.5

0.4

0.3

0.2

0.1

0.0
0.0

0.5

1.0

1.5

2.0

UDP-glucose (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.98497
START
0
0
END 0.72592
0.06097
k
1.01564
0.18022
n
1
0
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GalU E201A: varying [PPi]
Conditions: 0.6 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

0.6

Activity (nmol/min)

0.5
0.4
0.3
0.2
0.1
0.0
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.9947
START
0
0
END 1.12592
0.1132
k
0.94202
0.16175
n
1
0
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2+

GalF (pMCSG9): varying [Mg ]
Conditions: 4.4 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

1.2

Activity (nmol/min)

1.0
0.8
0.6
0.4
0.2
0.0
0

1

2

3

4

5

6

MgCl2 (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.97854
START
0
0
END 1.23893
0.12313
k
1.72281
0.30192
n
1.3944 0.2195
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GalF (pMCSG9): varying [UDP-Glc]
Conditions: 4.4 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.
2.5

Activity (nmol/min)

2.0

1.5

1.0

0.5

0.0
0.0

0.5

1.0

1.5

2.0

UDP-glucose (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99058
START
0
0
END 2.90082
0.17342
k
0.77778
0.10799
n
1
0
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GalF (pMCSG9): varying [PPi]
Conditions: 4.4 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

1.2

Activity (nmol/min)

1.0
0.8
0.6
0.4
0.2
0.0
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.95832
START
0
0
END 1.08417
0.04363
k
0.04131
0.00705
n
1.1
0
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GalF M15T H16R (pMCSG9): varying [UDP-Glc]
Conditions: 3 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

1.2

Activity (nmol/min)

1.0
0.8
0.6
0.4
0.2
0.0
0.0

0.5

1.0

1.5

2.0

UDP-glucose (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.99508
START
0
0
END 1.7037 0.07415
k
0.85466
0.08357
n
1
0
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GalF M15T H16R (pMCSG9): varying [PPi]
Conditions: 3 µg of the protein, Temperature: 30 °C, other conditions are the same as
described under the enzyme assay section in materials and methods.

0.7

Activity (nmol/min)

0.6
0.5
0.4
0.3
0.2
0.1
0.0
0.0

0.2

0.4

0.6

0.8

1.0

PPi (mM)

Equation: y = START + (END - START) * x^n / (k^n + x^n)
R^2 = 0.98422
START
0
0
END 0.71189
0.02271
k
0.06112
0.00775
n
1
0

APPENDIX B:
SUPLEMENTARY INFORMATION ABOUT PROTEIN MODELS
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Sequence alignment for the GalF model
1) galug[newline]structureX:galug: 138: A: 264: A:undefined:undefined:-1.00:-1.00; 2)
galuu [newline]structureX:galuu: 5: A: 298: A:undefined:undefined:-1.00:-1.00; 3) 2pa4a
[newline]structureX:2pa4a: 12: A: 326: A:undefined:undefined:-1.00:-1.00; 4) GALF
[newline]sequence:GALF: : : : :::-1.00:-1.001
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Verify3D graph for the GalF model
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Sequence alignment for the GalU model
1) galug[newline]structureX:galug: 138: A: 264: A:undefined:undefined:-1.00:-1.00; 2)
galuu [newline]structureX:galuu: 5: A: 298: A:undefined:undefined:-1.00:-1.00; 3) 2pa4a
[newline]structureX:2pa4a: 12: A: 326: A:undefined:undefined:-1.00:-1.00; 4) galu
[newline]sequence:galu: : : : :::-1.00:-1.001
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Verify3D graph for the GalU model
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